Aug 25 (Reuters) - Regis Healthcare Ltd REG.AX :
* FY 2017 EBITDA is anticipated to be in excess of 15% more than normalised FY
2016
* The company is expected to have higher depreciation charge than in FY 2016
* Says total capex spend is anticipated to be in the order of $160M in FY 2017
* Source text for Eikon ID:nASX4wkNmD
*